NASDAQ : CGON
CG Oncology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 63.47 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.63B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
CG Oncology, Inc. (CGON) reported revenue of 6.23M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 6.23M | 4.04M | 1.14M | 204.00K | 191.00K | 10.36M |
| Cost of Revenue | 167.76M | 121.29M | 82.10M | 45.75M | 29.03M | 18.32M |
| Gross Profit | -161.53M | -117.25M | -80.96M | -45.55M | -28.84M | -7.96M |
| Selling, General & Admin | 91.08M | 73.53M | 33.70M | 9.90M | 6.41M | 4.64M |
| Operating Expenses | 91.08M | 73.53M | 33.70M | 9.90M | 6.41M | 4.64M |
| Operating Income | -252.62M | -190.77M | -114.67M | -55.45M | -35.25M | -12.61M |
| Interest Expense | -1.00K | -451.00K | ||||
| Interest & Investment Income | 28.48M | 29.93M | 26.62M | 6.90M | 1.60M | |
| Other Non Operating Income (Expenses) | -238.00K | -152.00K | 3.00K | -62.00K | -1.80M | -182.00K |
| EBT Excluding Unusual Items | -224.38M | -161.00M | -88.04M | -48.61M | -35.44M | -13.24M |
| Other Unusual Items | 400.00K | |||||
| Pretax Income | -224.38M | -161.00M | -88.04M | -48.61M | -35.44M | -12.84M |
| Net Income | -224.38M | -161.00M | -88.04M | -48.61M | -35.44M | -12.84M |
| Preferred Dividends & Other Adjustments | 19.19M | 8.35M | 5.54M | |||
| Net Income to Common | -224.38M | -161.00M | -88.04M | -67.80M | -43.79M | -18.38M |
| Shares Outstanding (Basic) | 82.38M | 77.30M | 62.50M | 4.33M | 3.74M | 3.65M |
| Shares Outstanding (Diluted) | 82.38M | 77.30M | 62.50M | 4.33M | 3.74M | 3.65M |
| EPS (Basic) | -2.72 | -2.08 | -1.41 | -15.65 | -11.71 | -5.04 |
| EPS (Diluted) | -2.72 | -2.08 | -1.41 | -15.65 | -11.71 | -5.04 |
| Free Cash Flow | -179.34M | -132.48M | -78.95M | -45.68M | -29.82M | -13.75M |
| Free Cash Flow Per Share | -2.18 | -1.71 | -1.26 | -10.55 | -7.97 | -3.77 |
| Gross Margin | -76.86% | |||||
| Operating Margin | -4,056.18% | -4,722.13% | -10,067.25% | -27,180.88% | -18,453.40% | -121.70% |
| Profit Margin | -3,602.68% | -3,985.03% | -7,729.50% | -33,234.31% | -22,925.65% | -177.48% |
| Free Cash Flow Margin | -2,879.62% | -3,279.21% | -6,931.26% | -22,391.67% | -15,611.52% | -132.76% |
| EBITDA | -249.66M | -189.33M | -114.63M | -55.43M | -35.23M | -12.60M |
| EBITDA Margin | -121.61% | |||||
| D&A For EBITDA | 2.96M | 1.45M | 32.00K | 17.00K | 15.00K | 10.00K |
| EBIT | -252.62M | -190.77M | -114.67M | -55.45M | -35.25M | -12.61M |
| EBIT Margin | -121.70% | |||||
| Revenue as Reported | 6.23M | 4.04M | 1.14M | 204.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.64M | 32.49M | 257.07M | 8.27M | 88.14M | 53.61M |
| Short-Term Investments | 1.01B | 709.66M | 484.93M | 179.41M | 55.34M | |
| Cash & Short-Term Investments | 1.03B | 742.15M | 742.00M | 187.67M | 143.48M | 53.61M |
| Accounts Receivable | 417.00K | 688.00K | ||||
| Other Receivables | 92.00K | 303.00K | 2.00K | |||
| Receivables | 417.00K | 688.00K | 92.00K | 303.00K | 2.00K | |
| Inventory | 1.00M | 1.56M | ||||
| Prepaid Expenses | 19.95M | 15.07M | 12.21M | 6.36M | 3.42M | 4.80M |
| Total Current Assets | 1.05B | 759.48M | 754.21M | 194.12M | 147.21M | 58.41M |
| Property, Plant & Equipment | 20.44M | 19.57M | 493.00K | 491.00K | 506.00K | 200.00K |
| Goodwill | 10.30M | 10.30M | ||||
| Other Intangible Assets | 545.00K | 575.00K | ||||
| Long-Term Deferred Charges | 4.67M | |||||
| Other Long-Term Assets | 4.73M | 1.68M | 94.00K | 19.00K | 33.00K | 85.00K |
| Total Assets | 1.09B | 791.59M | 754.80M | 199.30M | 147.75M | 58.69M |
| Accounts Payable | 12.73M | 5.71M | 6.52M | 3.24M | 985.00K | 1.00M |
| Accrued Expenses | 31.85M | 23.12M | 14.23M | 9.68M | 5.12M | 1.89M |
| Current Portion of Long-Term Debt | 8.97M | 2.94M | ||||
| Current Portion of Leases | 985.00K | 915.00K | 186.00K | 217.00K | 189.00K | 72.00K |
| Current Unearned Revenue | 226.00K | 286.00K | ||||
| Other Current Liabilities | 1.45M | 802.00K | 436.00K | 1.12M | 173.00K | 68.00K |
| Total Current Liabilities | 47.24M | 30.84M | 21.37M | 14.25M | 15.43M | 5.97M |
| Long-Term Debt | 3.00M | 3.00M | 6.53M | 12.06M | ||
| Long-Term Leases | 4.83M | 3.11M | 52.00K | 244.00K | 257.00K | 50.00K |
| Long-Term Deferred Tax Liabilities | 307.00K | 307.00K | ||||
| Other Long-Term Liabilities | 1.16M | 1.74M | 13.00K | 352.00K | 351.00K | |
| Total Liabilities | 56.54M | 38.99M | 21.42M | 14.51M | 22.57M | 18.44M |
| Common Stock | 9.00K | 8.00K | 8.00K | 3.00K | ||
| Additional Paid-In Capital | 1.55B | 1.13B | 951.35M | 6.84M | 3.64M | 3.27M |
| Retained Earnings | -518.23M | -378.98M | -217.98M | -129.94M | -81.33M | -45.89M |
| Total Common Equity | 1.03B | 752.60M | 733.38M | -123.10M | -77.69M | -42.62M |
| Shareholders' Equity | 1.03B | 752.60M | 733.38M | 184.79M | 125.18M | 40.25M |
| Total Liabilities & Equity | 1.09B | 791.59M | 754.80M | 199.30M | 147.75M | 58.69M |
| Total Debt | 8.82M | 7.02M | 238.00K | 461.00K | 15.94M | 15.13M |
| Net Cash (Debt) | 1.02B | 735.13M | 741.76M | 187.21M | 127.54M | 38.48M |
| Net Cash Per Share | 12.37 | 9.51 | 11.87 | 43.23 | 34.09 | 10.54 |
| Filing Date Shares Outstanding | 88.64M | 84.44M | 76.22M | 66.64M | 3.84M | 3.65M |
| Total Common Shares Outstanding | 88.31M | 80.69M | 76.15M | 5.22M | 3.84M | 3.65M |
| Working Capital | 1.00B | 728.64M | 732.84M | 179.87M | 131.78M | 52.43M |
| Book Value Per Share | 11.65 | 9.33 | 9.63 | -23.57 | -20.22 | -11.67 |
| Tangible Book Value | 1.02B | 741.73M | 733.38M | -123.10M | -77.69M | -42.62M |
| Tangible Book Value Per Share | 11.53 | 9.19 | 9.63 | -23.57 | -20.22 | -11.67 |
| Machinery | 7.05M | 6.57M | 359.00K | |||
| Leasehold Improvements | 10.71M | 10.50M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -224.38M | -161.00M | -88.04M | -48.61M | -35.44M | -12.84M |
| Depreciation & Amortization | 2.96M | 1.45M | 32.00K | 17.00K | 15.00K | 10.00K |
| Other Amortization | 3.00K | 12.00K | 11.00K | |||
| Loss (Gain) From Sale of Investments | 5.82M | -1.01M | -4.99M | -2.88M | ||
| Stock-Based Compensation | 35.33M | 26.68M | 11.40M | 1.53M | 676.00K | 1.11M |
| Other Operating Activities | 58.00K | -734.00K | -22.00K | 816.00K | 497.00K | 19.00K |
| Change in Accounts Receivable | -49.00K | -320.00K | ||||
| Change in Inventory | 118.00K | -444.00K | ||||
| Change in Accounts Payable | 4.76M | -1.64M | 3.27M | 2.01M | -18.00K | 578.00K |
| Change in Other Net Operating Assets | -3.08M | 4.68M | -369.00K | 1.43M | 4.46M | -2.54M |
| Operating Cash Flow | -178.47M | -132.35M | -78.71M | -45.68M | -29.80M | -13.65M |
| Capital Expenditures | -876.00K | -134.00K | -234.00K | -14.00K | -97.00K | |
| Cash Acquisitions | -21.97M | -21.97M | ||||
| Investment in Securities | -368.03M | -223.72M | -300.53M | -121.19M | -55.34M | |
| Investing Cash Flow | -364.88M | -245.82M | -300.76M | -121.19M | -55.35M | -97.00K |
| Long-Term Debt Issued | 15.20M | |||||
| Long-Term Debt Repaid | -365.00K | -16.29M | ||||
| Net Debt Issued (Repaid) | -365.00K | -16.29M | 15.20M | |||
| Issuance of Common Stock | 548.50M | 153.91M | 632.07M | 2.08M | 166.00K | 245.00K |
| Other Financing Activities | 45.00K | -316.00K | -3.42M | -3.42M | -474.00K | |
| Financing Cash Flow | 548.36M | 153.59M | 628.28M | 87.00M | 119.69M | 15.45M |
| Net Cash Flow | 5.01M | -224.58M | 248.80M | -79.88M | 34.54M | 1.70M |
| Free Cash Flow | -179.34M | -132.48M | -78.95M | -45.68M | -29.82M | -13.75M |
| Free Cash Flow Margin | -2,879.62% | -3,279.21% | -6,931.26% | -22,391.67% | -15,611.52% | -132.76% |
| Free Cash Flow Per Share | -2.18 | -1.71 | -1.26 | -10.55 | -7.97 | -3.77 |
| Levered Free Cash Flow | -113.71M | -87.62M | -59.08M | -28.07M | -16.95M | |
| Unlevered Free Cash Flow | -113.71M | -87.62M | -59.08M | -28.07M | -16.96M | |
| Cash Interest Paid | 197.00K | 103.00K | 376.00K | 1.09M | 314.00K | |
| Cash Income Tax Paid | 18.00K | 16.00K | ||||
| Change in Working Capital | 1.75M | 2.28M | 2.91M | 3.44M | 4.44M | -1.97M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.73B | 3.35B | 2.18B | |||
| Enterprise Value | 4.71B | 2.68B | 1.64B | |||
| Last Close Price | 64.68 | 41.52 | 28.68 | |||
| PS Ratio | 920.56 | 829.02 | 1,916.94 | |||
| PB Ratio | 5.55 | 4.45 | 2.98 | |||
| P/TBV Ratio | 5.63 | 4.51 | 2.98 | |||
| EV/Sales Ratio | 756.87 | 662.43 | 1,442.48 | |||
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.13 | 0.38 |
| Net Debt / Equity Ratio | -0.99 | -0.98 | -1.01 | -1.01 | -1.02 | -0.96 |
| Net Debt / EBITDA Ratio | 4.08 | 3.88 | 6.47 | 3.38 | 3.62 | 3.06 |
| Net Debt / FCF Ratio | 5.68 | 5.55 | 9.40 | 4.10 | 4.28 | 2.80 |
| Asset Turnover | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Quick Ratio | 21.78 | 24.09 | 34.73 | 13.17 | 9.32 | 8.97 |
| Current Ratio | 22.22 | 24.63 | 35.30 | 13.62 | 9.54 | 9.78 |
| Return on Equity (ROE) | -26.41% | -21.67% | -19.18% | -31.36% | -42.85% | |
| Return on Assets (ROA) | -17.67% | -15.42% | -15.02% | -19.97% | -21.34% | |
| Return on Capital Employed (ROCE) | -24.30% | -25.10% | -15.60% | -30.00% | -26.60% | -23.90% |
| Earnings Yield | -4.21% | -4.81% | -4.03% | |||
| FCF Yield | -3.13% | -3.96% | -3.62% | |||
| Buyback Yield / Dilution | -14.15% | -23.69% | -1,343.03% | -15.77% | -2.48% |